One of the most nuanced areas of diabetes management has become a focal point for diabetes care and education specialists: use of new technologies to improve care. With many in patient-facing roles, optimal uptake and dissemination of information, and the technologies themselves, have led to diabetes technology becoming a main topic of discussion at the Association of Diabetes Care and Education Specialists (ADCES) annual meeting and for good reason. In just the first half of 2022, major regulatory decisions have been made related to Omnipod 5, Eversense E3, and the FreeStylen Libre 3 devices.
With an interest in learning more about the real-world need for diabetes care and education specialists in advancing use of continuous glucose monitoring and other diabetes-centric technology, EndocrinologyNetwork sat down Gary Scheiner, MS, CDE, owner and clinical director of Integrated Diabetes Services, at the ADCES 2022 annual meeting for his perspective on the ever-changing landscape. That conversation is the subject of the video found below: